血栓管理設備市場－全球產業規模、佔有率、趨勢、機會和預測（按產品類型、最終用戶、地區和競爭細分，2020-2030 年）

2024 年全球血栓管理設備市場價值為 18.5 億美元，預計到 2030 年將達到 24.7 億美元，預測期內的複合年成長率為 5.11%。全球血栓管理設備市場正在穩步成長，這得益於心血管疾病、深部靜脈栓塞和中風發病率的上升。這些設備在血栓的診斷、預防和治療中起著至關重要的作用，如果不及時治療，血栓會導致危及生命的疾病。隨著醫療技術的進步，對微創手術的需求不斷增加，推動了醫院和門診環境中血栓檢索和抽吸設備的應用。血栓管理的技術創新，包括機械血栓切除系統和導管引導血栓溶解，正在改善臨床療效並縮短復原時間。這些發展正在提高護理標準，特別是在時間至關重要的急性缺血性中風病例中。此外，人口老化和久坐不動生活方式的日益盛行導致血栓栓塞性疾病的風險增加，進一步刺激了市場需求。例如，根據2022年4月發表的《COVID-19中的心血管疾病管理》一文，包括血栓形成在內的凝血問題已在全球範圍內與COVID-19感染廣泛相關。研究表明，該病毒會增加血栓栓塞併發症的風險，凸顯了有效的血栓管理在治療COVID-19患者和降低疫情期間相關心血管風險的重要性。

醫療保健提供者越來越認知到使用血栓管理設備進行早期干預的益處，這有助於減輕長期併發症的負擔和醫療成本。這一趨勢在擁有先進醫療基礎設施的已開發地區尤為明顯。同時，由於醫療保健管道的改善和人們意識的不斷提高，新興經濟體也逐漸採用這些設備。支持性報銷政策和正在進行的臨床研究也對市場產生了影響，這些研究驗證了新型血栓管理技術的安全性和有效性。然而，諸如設備成本高昂、農村地區難以獲得以及對熟練專業人員的需求等挑戰可能會阻礙某些地區的成長。在臨床需求、技術進步以及對主動醫療干預日益成長的關注的支持下，全球血栓管理設備市場有望擴張。市場參與者可能會投資於研發，以提供創新解決方案，從而改善病患治療效果，並滿足發達和發展中醫療體系中尚未滿足的醫療需求。

關鍵市場促進因素

血栓栓塞性疾病盛行率上升

主要市場挑戰

設備和手術成本高昂

主要市場趨勢

轉向微創手術

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：顧客之聲

第5章：全球血塊管理設備市場展望

• 市場規模和預測
  • 按價值
• 市場佔有率和預測
  • 依產品類型（神經血管栓塞切除裝置、栓塞切除球囊導管、經皮血栓切除裝置、導管定向血栓溶解裝置、其他）
  • 按最終使用者（醫院和診所、門診護理中心、其他）
  • 按公司分類（2024）
  • 按地區
• 市場地圖
  • 依產品類型
  • 按最終用戶
  • 按地區

第6章：北美血塊管理設備市場展望

• 市場規模和預測
• 市場佔有率和預測
• 北美：國家分析
  • 美國
  • 墨西哥
  • 加拿大

第7章：歐洲血塊管理設備市場展望

• 市場規模和預測
• 市場佔有率和預測
• 歐洲：國家分析
  • 法國
  • 德國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區血塊管理設備市場展望

• 市場規模和預測
• 市場佔有率和預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 韓國
  • 日本
  • 澳洲

第9章：南美洲血塊管理設備市場展望

• 市場規模和預測
• 市場佔有率和預測
• 南美洲：國家分析
  • 巴西
  • 阿根廷
  • 哥倫比亞

第 10 章：中東和非洲血塊管理設備市場展望

• 市場規模和預測
• 市場佔有率和預測
• MEA：國家分析
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第 11 章：市場動態

• 驅動程式
• 挑戰

第 12 章：市場趨勢與發展

• 最新動態
• 併購
• 產品發布

第 13 章：競爭格局

• Medtronic Plc.
• Concentric Medical, Inc.
• Boston Scientific Corporation
• Edward LifeSciences Corporation
• AngioDynamics, Inc.
• LeMaitre Vascular, Inc.
• Teleflex Incorporated
• Johnson & Johnson
• Strub Medical GmbH & Co. KG
• Cook Group Incorporated

第 14 章：策略建議

第15章調查會社について,免責事項

Global Clot Management Devices Market was valued at USD 1.85 billion in 2024 and is expected to reach USD 2.47 billion by 2030 with a CAGR of 5.11% during the forecast period. The global clot management devices market is witnessing steady growth, driven by the rising incidence of cardiovascular diseases, deep vein thrombosis, and stroke. These devices play a crucial role in the diagnosis, prevention, and treatment of blood clots that can lead to life-threatening conditions if left untreated. As medical technology advances, the demand for minimally invasive procedures is increasing, fueling the adoption of clot retrieval and aspiration devices in both hospitals and outpatient settings. Technological innovations in clot management, including mechanical thrombectomy systems and catheter-directed thrombolysis, are enhancing clinical outcomes and reducing recovery times. These developments are improving the standard of care, particularly in acute ischemic stroke cases where time is critical. Furthermore, the aging population and rising prevalence of sedentary lifestyles contribute to a higher risk of thromboembolic disorders, further boosting market demand. For instance, according to the article "Cardiovascular Disease Management in COVID-19," published in April 2022, blood coagulation issues, including clot formation, have been widely associated with COVID-19 infections worldwide. The virus has been shown to increase the risk of thromboembolic complications, highlighting the importance of effective clot management in treating COVID-19 patients and reducing related cardiovascular risks during the pandemic.

Healthcare providers are increasingly recognizing the benefits of early intervention with clot management devices to reduce the burden of long-term complications and healthcare costs. This trend is particularly evident in developed regions with advanced healthcare infrastructure. Meanwhile, emerging economies are gradually adopting these devices due to improving healthcare access and growing awareness. The market is also influenced by supportive reimbursement policies and ongoing clinical research that validates the safety and efficacy of new clot management technologies. However, challenges such as the high cost of devices, limited access in rural areas, and the need for skilled professionals may hinder growth in some regions. The global clot management devices market is poised for expansion, supported by clinical necessity, technological advancement, and a growing focus on proactive healthcare interventions. Market players are likely to invest in research and development to offer innovative solutions that improve patient outcomes and address unmet medical needs across both developed and developing healthcare systems.

Key Market Drivers

Rising Prevalence of Thromboembolic Disorders

Rising prevalence of thromboembolic disorders is one of the most significant factors propelling the growth of the global clot management devices market. For instance, the World Health Organization (WHO) estimates that by 2050, the global population aged 60 and above will reach 2.1 billion, more than doubling from 1 billion in 2020. This demographic shift highlights the growing need for age-related healthcare solutions, including advanced clot management devices.

Conditions such as deep vein thrombosis (DVT), pulmonary embolism (PE), and ischemic stroke are becoming increasingly common due to lifestyle changes, aging populations, and growing rates of chronic diseases such as obesity, diabetes, and hypertension. These disorders result from the formation of blood clots that obstruct normal blood flow, posing life-threatening risks if not treated promptly. Clot management devices, including thrombectomy systems and catheter-directed thrombolysis tools, are essential for the rapid and effective removal of these clots, helping to prevent complications and reduce mortality. The sedentary nature of modern life, prolonged immobility, and increased incidences of surgical procedures contribute to higher rates of venous thromboembolism. In particular, stroke continues to be a leading cause of death and disability worldwide, placing a significant burden on healthcare systems. With early intervention proving crucial in managing thromboembolic events, hospitals and clinics are increasingly investing in advanced clot management technologies that provide quicker, safer, and more targeted treatment options. Health professionals are recognizing the importance of timely clot removal to avoid permanent damage or fatal outcomes. The growing awareness among patients and clinicians about the risks associated with untreated clots and the benefits of early treatment is leading to increased demand for these devices. This trend underscores the urgency of improving diagnostic capabilities and expanding access to life-saving clot management solutions, especially in high-risk populations.

Key Market Challenges

High Cost of Devices and Procedures

The high cost of devices and procedures is a significant challenge impacting the growth of the global clot management devices market. Advanced clot management systems, such as mechanical thrombectomy devices and catheter-directed thrombolysis tools, often come with substantial price tags. These costs extend beyond the devices themselves and include expenses related to specialized imaging equipment, procedural tools, maintenance, and skilled personnel required to operate them. Hospitals and clinics, particularly in low- and middle-income regions, may struggle to justify these investments given limited healthcare budgets and competing priorities. For patients, high treatment costs can lead to financial strain, especially in areas where health insurance coverage is insufficient or unavailable. Even in developed markets, reimbursement issues can affect both patients and healthcare providers. When coverage is limited or inconsistent, facilities may hesitate to adopt new technologies despite their clinical benefits. This reluctance can delay access to potentially life-saving treatments and contribute to disparities in care across different populations and regions. Cost challenges also impact research and development. Companies aiming to innovate must balance the need for cutting-edge features with the demand for affordability and cost-effectiveness. Striking this balance is complex and can slow down the commercialization of novel technologies. High costs may restrict the use of these devices to well-equipped urban centers, limiting availability in rural or under-resourced areas.

Addressing this challenge requires strategic pricing models, supportive reimbursement policies, and innovations focused on reducing production costs without compromising quality or performance. Lowering economic barriers is essential for expanding access and ensuring broader adoption of clot management technologies.

Key Market Trends

Shift Toward Minimally Invasive Procedures

The shift toward minimally invasive procedures is playing a critical role in driving the growth of the global clot management devices market. Traditional open surgical methods for removing clots often involve greater risk, longer hospital stays, and extended recovery periods. In contrast, minimally invasive techniques, such as catheter-directed thrombolysis and mechanical thrombectomy, offer effective treatment with reduced trauma to the body, faster patient recovery, and shorter hospitalization. These benefits make them increasingly attractive to both healthcare providers and patients. Minimally invasive procedures allow physicians to access and treat clots through small incisions or punctures, often using image-guided tools for precise navigation. This approach significantly reduces complications such as bleeding, infection, and tissue damage, which are more common in open surgeries. As a result, these procedures are being adopted widely in the management of deep vein thrombosis, pulmonary embolism, and ischemic stroke. Healthcare systems are also recognizing the economic advantages of these procedures. Shorter recovery times translate to lower hospital costs, quicker patient turnover, and better resource allocation. In many cases, patients can be treated in outpatient or ambulatory care settings, reducing the burden on hospitals and improving accessibility.

Medical device manufacturers are responding to this trend by developing compact, user-friendly devices that support rapid intervention and high procedural success rates. As patient demand grows for less invasive treatment options, and as medical professionals seek efficient and safe alternatives to surgery, the market for minimally invasive clot management devices is expected to expand significantly in both developed and emerging healthcare settings.

Key Market Players

• Medtronic Plc.
• Concentric Medical, Inc.
• Boston Scientific Corporation
• Edward LifeSciences Corporation
• AngioDynamics, Inc.
• LeMaitre Vascular, Inc.
• Teleflex Incorporated
• Johnson & Johnson
• Strub Medical GmbH & Co. KG
• Cook Group Incorporated

Report Scope:

In this report, the Global Clot Management Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Clot Management Devices Market, By Product Type:

• Neurovascular Embolectomy Devices
• Embolectomy Balloon Catheters
• Percutaneous Thrombectomy Devices
• Catheter Directed Thrombolysis Devices
• Others

Clot Management Devices Market, By End User:

• Academic & Research Institutes
• Hospital & Diagnostic Laboratories
• Pharmaceutical & Biotechnology Companies

Clot Management Devices Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Clot Management Devices Market.

Available Customizations:

Global Clot Management Devices Market report with the given Market data, TechSci Research, offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional Market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Clot Management Devices Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product Type (Neurovascular Embolectomy Devices, Embolectomy Balloon Catheters, Percutaneous Thrombectomy Devices, Catheter Directed Thrombolysis Devices, Others)
  • 5.2.2. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)
  • 5.2.3. By Company (2024)
  • 5.2.4. By Region
• 5.3. Market Map
  • 5.3.1. By Product Type
  • 5.3.2. By End User
  • 5.3.3. By Region

6. North America Clot Management Devices Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product Type
  • 6.2.2. By End User
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Clot Management Devices Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product Type
      • 6.3.1.2.2. By End User
  • 6.3.2. Mexico Clot Management Devices Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product Type
      • 6.3.2.2.2. By End User
  • 6.3.3. Canada Clot Management Devices Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product Type
      • 6.3.3.2.2. By End User

7. Europe Clot Management Devices Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product Type
  • 7.2.2. By End User
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Clot Management Devices Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product Type
      • 7.3.1.2.2. By End User
  • 7.3.2. Germany Clot Management Devices Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product Type
      • 7.3.2.2.2. By End User
  • 7.3.3. United Kingdom Clot Management Devices Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product Type
      • 7.3.3.2.2. By End User
  • 7.3.4. Italy Clot Management Devices Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product Type
      • 7.3.4.2.2. By End User
  • 7.3.5. Spain Clot Management Devices Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product Type
      • 7.3.5.2.2. By End User

8. Asia-Pacific Clot Management Devices Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product Type
  • 8.2.2. By End User
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Clot Management Devices Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product Type
      • 8.3.1.2.2. By End User
  • 8.3.2. India Clot Management Devices Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product Type
      • 8.3.2.2.2. By End User
  • 8.3.3. South Korea Clot Management Devices Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product Type
      • 8.3.3.2.2. By End User
  • 8.3.4. Japan Clot Management Devices Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product Type
      • 8.3.4.2.2. By End User
  • 8.3.5. Australia Clot Management Devices Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product Type
      • 8.3.5.2.2. By End User

9. South America Clot Management Devices Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product Type
  • 9.2.2. By End User
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Clot Management Devices Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product Type
      • 9.3.1.2.2. By End User
  • 9.3.2. Argentina Clot Management Devices Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product Type
      • 9.3.2.2.2. By End User
  • 9.3.3. Colombia Clot Management Devices Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product Type
      • 9.3.3.2.2. By End User

10. Middle East and Africa Clot Management Devices Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product Type
  • 10.2.2. By End User
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Clot Management Devices Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product Type
      • 10.3.1.2.2. By End User
  • 10.3.2. Saudi Arabia Clot Management Devices Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product Type
      • 10.3.2.2.2. By End User
  • 10.3.3. UAE Clot Management Devices Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product Type
      • 10.3.3.2.2. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Competitive Landscape

• 13.1. Medtronic Plc.
• 13.2. Concentric Medical, Inc.
• 13.3. Boston Scientific Corporation
• 13.4. Edward LifeSciences Corporation
• 13.5. AngioDynamics, Inc.
• 13.6. LeMaitre Vascular, Inc.
• 13.7. Teleflex Incorporated
• 13.8. Johnson & Johnson
• 13.9. Strub Medical GmbH & Co. KG
• 13.10. Cook Group Incorporated

14. Strategic Recommendations

15. About Us & Disclaimer